Ascorbyl Palmitate Reduced Dissolution Claim Unsupported – NAD
This article was originally published in The Tan Sheet
Thorne Research will continue to urge physicians to compare dissolution rates between dietary supplements with and without insoluble excipients following an inquiry by the National Advertising Division of the Council of Better Business Bureaus
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC